171 related articles for article (PubMed ID: 38726227)
1. Formulation of silymarin surface modified vesicles: In vitro characterization to cell viability assessment.
Imam SS; Alshammari SO; Alshehri S; Mahdi WA; Al-Agamy MH
Saudi Pharm J; 2024 Jun; 32(6):102072. PubMed ID: 38726227
[TBL] [Abstract][Full Text] [Related]
2. Formulation of Chitosan-Coated Apigenin Bilosomes: In Vitro Characterization, Antimicrobial and Cytotoxicity Assessment.
Imam SS; Alshehri S; Altamimi MA; Almalki RKH; Hussain A; Bukhari SI; Mahdi WA; Qamar W
Polymers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267744
[TBL] [Abstract][Full Text] [Related]
3. Formulation of Isopropyl Isothiocyanate Loaded Nano Vesicles Delivery Systems: In Vitro Characterization and In Vivo Assessment.
Kala C; Asif M; Gilani SJ; Imam SS; Khan NA; Taleuzzaman M; Zafar A; Ahmed MM; Alshehri S; Ghoneim MM
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566224
[TBL] [Abstract][Full Text] [Related]
4. Integrating Artificial Intelligence with Quality by Design in the Formulation of Lecithin/Chitosan Nanoparticles of a Poorly Water-Soluble Drug.
Dawoud MHS; Mannaa IS; Abdel-Daim A; Sweed NM
AAPS PharmSciTech; 2023 Aug; 24(6):169. PubMed ID: 37552427
[TBL] [Abstract][Full Text] [Related]
5. Formulation and Evaluation of Luteolin-Loaded Nanovesicles:
Imam SS; Alshehri S; Altamimi MA; Hussain A; Alyahya KH; Mahdi WA; Qamar W
ACS Omega; 2022 Jan; 7(1):1048-1056. PubMed ID: 35036768
[TBL] [Abstract][Full Text] [Related]
6. Effects of silymarin-loaded amphiphilic chitosan polymeric micelles on the renal toxicity and anticancer activity of cisplatin.
Soodvilai S; Tipparos W; Rangsimawong W; Patrojanasophon P; Soodvilai S; Sajomsang W; Opanasopit P
Pharm Dev Technol; 2019 Oct; 24(8):927-934. PubMed ID: 30526167
[TBL] [Abstract][Full Text] [Related]
7. Formulation of silymarin binary and ternary solid dispersions: Characterization, simulation study and cell viability assessment against lung cancer cell line.
Alkathiri FA; Bukhari SI; Imam SS; Alshehri S; Mahdi WA
Heliyon; 2024 Jan; 10(1):e23221. PubMed ID: 38163135
[TBL] [Abstract][Full Text] [Related]
8. Formulation of Silymarin-β Cyclodextrin-TPGS Inclusion Complex: Physicochemical Characterization, Molecular Docking, and Cell Viability Assessment against Breast Cancer Cell Lines.
Imam SS; Alshehri S; Altamimi MA; Mahdi WA; Qamar W
ACS Omega; 2023 Sep; 8(38):34898-34907. PubMed ID: 37779986
[TBL] [Abstract][Full Text] [Related]
9. Formulation, Optimization and Evaluation of Luteolin-Loaded Topical Nanoparticulate Delivery System for the Skin Cancer.
Kazmi I; Al-Abbasi FA; Nadeem MS; Altayb HN; Alshehri S; Imam SS
Pharmaceutics; 2021 Oct; 13(11):. PubMed ID: 34834164
[TBL] [Abstract][Full Text] [Related]
10. Freeze-dryable lipid vesicles with size tunability and high encapsulation efficiency prepared by the multiple emulsification-solvent evaporation method.
Suzuki A; Kuroiwa T; Horikoshi K; Kanazawa A; Ichikawa S
Colloids Surf B Biointerfaces; 2017 Nov; 159():412-418. PubMed ID: 28822290
[TBL] [Abstract][Full Text] [Related]
11. Formulation of Piperine-Chitosan-Coated Liposomes: Characterization and In Vitro Cytotoxic Evaluation.
Imam SS; Alshehri S; Altamimi MA; Hussain A; Qamar W; Gilani SJ; Zafar A; Alruwaili NK; Alanazi S; Almutairy BK
Molecules; 2021 May; 26(11):. PubMed ID: 34072306
[TBL] [Abstract][Full Text] [Related]
12. Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment.
Ameeduzzafar ; Alruwaili NK; Imam SS; Alotaibi NH; Alhakamy NA; Alharbi KS; Alshehri S; Afzal M; Alenezi SK; Bukhari SNA
AAPS PharmSciTech; 2020 Jun; 21(5):167. PubMed ID: 32504176
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of luteolin loaded pegylated bilosome: optimization,
Zafar A; Alruwaili NK; Imam SS; Alsaidan OA; Yasir M; Ghoneim MM; Alshehri S; Anwer MK; Almurshedi AS; Alanazi AS
Drug Deliv; 2021 Dec; 28(1):2562-2573. PubMed ID: 34866534
[TBL] [Abstract][Full Text] [Related]
14. Lornoxicam-Loaded Chitosan-Decorated Nanoemulsion: Preparation and In Vitro Evaluation for Enhanced Transdermal Delivery.
Khan RU; Shah SU; Rashid SA; Naseem F; Shah KU; Farid A; Hakeem KR; Kamli MR; Althubaiti EH; Alamoudi SA
Polymers (Basel); 2022 May; 14(9):. PubMed ID: 35567091
[TBL] [Abstract][Full Text] [Related]
15. Silymarin encapsulated poly(D,L-lactic-co-glycolic acid) nanoparticles: a prospective candidate for prostate cancer therapy.
Snima KS; Arunkumar P; Jayakumar R; Lakshmanan VK
J Biomed Nanotechnol; 2014 Apr; 10(4):559-70. PubMed ID: 24734508
[TBL] [Abstract][Full Text] [Related]
16. Targeting silymarin for improved hepatoprotective activity through chitosan nanoparticles.
Gupta S; Singh SK; Girotra P
Int J Pharm Investig; 2014 Oct; 4(4):156-63. PubMed ID: 25426436
[TBL] [Abstract][Full Text] [Related]
17. Nanostructured lipid carriers for oral delivery of silymarin: Improving its absorption and in vivo efficacy in type 2 diabetes and metabolic syndrome model.
Piazzini V; Micheli L; Luceri C; D'Ambrosio M; Cinci L; Ghelardini C; Bilia AR; Di Cesare Mannelli L; Bergonzi MC
Int J Pharm; 2019 Dec; 572():118838. PubMed ID: 31715362
[TBL] [Abstract][Full Text] [Related]
18. Experimental Design Supported Liposomal Aztreonam Delivery:
Bhattacharyya S; Sudheer P; Das K; Ray S
Adv Pharm Bull; 2021 Sep; 11(4):651-662. PubMed ID: 34888212
[No Abstract] [Full Text] [Related]
19. Bioactive Apigenin loaded oral nano bilosomes: Formulation optimization to preclinical assessment.
Zafar A; Alruwaili NK; Imam SS; Hadal Alotaibi N; Alharbi KS; Afzal M; Ali R; Alshehri S; Alzarea SI; Elmowafy M; Alhakamy NA; Ibrahim MF
Saudi Pharm J; 2021 Mar; 29(3):269-279. PubMed ID: 33981176
[TBL] [Abstract][Full Text] [Related]
20. Neural Network-based Optimization of
Hanafi A; Safa KD; Rezazadeh S
Curr Comput Aided Drug Des; 2023; 19(1):2-12. PubMed ID: 36221887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
